Why may real world data not always reflect what was learned in a clinical trial?

Why may real world data not always reflect what was learned in a clinical trial?
How can real world evidence lead to FDA label changes?
How can real world data be used to guide treatment decision making?
When should bone marrow biopsies be repeated?